APO Research

APO RESEARCH · REPORT

Anti-infective Drugs for Animals

Selected research

Market Analysis & Forecast

Global Anti-infective Drugs for Animals Market Analysis and Forecast 2026-2032

Market perspective

The global Anti-infective Drugs for Animals market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Anti-infective Drugs for Animals is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Anti-infective Drugs for Animals is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Anti-infective Drugs for Animals is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Anti-infective Drugs for Animals is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Anti-infective Drugs for Animals include AG Supply, Vetoquinol SA, Bayer, Boehringer Ingelheim, Phibro Animal Health Corporation, Elanco, Merck, Ceva Santé Animale and Zoetis Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Anti-infective Drugs for Animals, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Anti-infective Drugs for Animals, also provides the sales of main regions and countries. Of the upcoming market potential for Anti-infective Drugs for Animals, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anti-infective Drugs for Animals sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Anti-infective Drugs for Animals market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Anti-infective Drugs for Animals sales, projected growth trends, production technology, application and end-user industry.

Anti-infective Drugs for Animals Segment by Company

AG Supply

Vetoquinol SA

Bayer

Boehringer Ingelheim

Phibro Animal Health Corporation

Elanco

Merck

Ceva Santé Animale

Zoetis Inc.

Anti-infective Drugs for Animals Segment by Type

Antifungals

Antibacterial

Antivirals

Others

Anti-infective Drugs for Animals Segment by Application

Cattle

Cats

Dogs

Other Animals

Anti-infective Drugs for Animals Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-infective Drugs for Animals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-infective Drugs for Animals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-infective Drugs for Animals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Anti-infective Drugs for Animals in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Anti-infective Drugs for Animals manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-infective Drugs for Animals sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Anti-infective Drugs for Animals Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Antifungals Major Manufacturers Table 3. Antibacterial Major Manufacturers Table 4. Antivirals Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Anti-infective Drugs for Animals Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Cattle Major Manufacturers Table 8. Cats Major Manufacturers Table 9. Dogs Major Manufacturers Table 10. Other Animals Major Manufacturers Table 11. Anti-infective Drugs for Animals Industry Trends Table 12. Anti-infective Drugs for Animals Industry Drivers Table 13. Anti-infective Drugs for Animals Industry Opportunities and Challenges Table 14. Anti-infective Drugs for Animals Industry Restraints Table 15. Global Anti-infective Drugs for Animals Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Anti-infective Drugs for Animals Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Anti-infective Drugs for Animals Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Anti-infective Drugs for Animals Revenue Market Share by Region (2021-2026) Table 19. Global Anti-infective Drugs for Animals Revenue Market Share by Region (2027-2032) Table 20. Global Anti-infective Drugs for Animals Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Anti-infective Drugs for Animals Sales by Region (2021-2026) & (K Units) Table 22. Global Anti-infective Drugs for Animals Sales by Region (2027-2032) & (K Units) Table 23. Global Anti-infective Drugs for Animals Sales Market Share by Region (2021-2026) Table 24. Global Anti-infective Drugs for Animals Sales Market Share by Region (2027-2032) Table 25. Global Anti-infective Drugs for Animals Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Anti-infective Drugs for Animals Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Anti-infective Drugs for Animals Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Anti-infective Drugs for Animals Sales Market Share by Manufacturers (2021-2026) Table 29. Global Anti-infective Drugs for Animals Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Anti-infective Drugs for Animals Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Anti-infective Drugs for Animals Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Anti-infective Drugs for Animals Manufacturers, Product Type & Application Table 33. Global Anti-infective Drugs for Animals Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Anti-infective Drugs for Animals by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Anti-infective Drugs for Animals Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Anti-infective Drugs for Animals Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Anti-infective Drugs for Animals Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Anti-infective Drugs for Animals Revenue Market Share by Type (2021-2026) Table 40. Global Anti-infective Drugs for Animals Revenue Market Share by Type (2027-2032) Table 41. Global Anti-infective Drugs for Animals Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Anti-infective Drugs for Animals Sales by Type (2021-2026) & (K Units) Table 43. Global Anti-infective Drugs for Animals Sales by Type (2027-2032) & (K Units) Table 44. Global Anti-infective Drugs for Animals Sales Market Share by Type (2021-2026) Table 45. Global Anti-infective Drugs for Animals Sales Market Share by Type (2027-2032) Table 46. Global Anti-infective Drugs for Animals Price by Type (2021-2026) & (US$/Unit) Table 47. Global Anti-infective Drugs for Animals Price by Type (2027-2032) & (US$/Unit) Table 48. Global Anti-infective Drugs for Animals Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Anti-infective Drugs for Animals Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Anti-infective Drugs for Animals Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Anti-infective Drugs for Animals Revenue Market Share by Application (2021-2026) Table 52. Global Anti-infective Drugs for Animals Revenue Market Share by Application (2027-2032) Table 53. Global Anti-infective Drugs for Animals Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Anti-infective Drugs for Animals Sales by Application (2021-2026) & (K Units) Table 55. Global Anti-infective Drugs for Animals Sales by Application (2027-2032) & (K Units) Table 56. Global Anti-infective Drugs for Animals Sales Market Share by Application (2021-2026) Table 57. Global Anti-infective Drugs for Animals Sales Market Share by Application (2027-2032) Table 58. Global Anti-infective Drugs for Animals Price by Application (2021-2026) & (US$/Unit) Table 59. Global Anti-infective Drugs for Animals Price by Application (2027-2032) & (US$/Unit) Table 60. AG Supply Company Information Table 61. AG Supply Business Overview Table 62. AG Supply Anti-infective Drugs for Animals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. AG Supply Anti-infective Drugs for Animals Product Portfolio Table 64. AG Supply Recent Development Table 65. Vetoquinol SA Company Information Table 66. Vetoquinol SA Business Overview Table 67. Vetoquinol SA Anti-infective Drugs for Animals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Vetoquinol SA Anti-infective Drugs for Animals Product Portfolio Table 69. Vetoquinol SA Recent Development Table 70. Bayer Company Information Table 71. Bayer Business Overview Table 72. Bayer Anti-infective Drugs for Animals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Bayer Anti-infective Drugs for Animals Product Portfolio Table 74. Bayer Recent Development Table 75. Boehringer Ingelheim Company Information Table 76. Boehringer Ingelheim Business Overview Table 77. Boehringer Ingelheim Anti-infective Drugs for Animals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Boehringer Ingelheim Anti-infective Drugs for Animals Product Portfolio Table 79. Boehringer Ingelheim Recent Development Table 80. Phibro Animal Health Corporation Company Information Table 81. Phibro Animal Health Corporation Business Overview Table 82. Phibro Animal Health Corporation Anti-infective Drugs for Animals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Phibro Animal Health Corporation Anti-infective Drugs for Animals Product Portfolio Table 84. Phibro Animal Health Corporation Recent Development Table 85. Elanco Company Information Table 86. Elanco Business Overview Table 87. Elanco Anti-infective Drugs for Animals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Elanco Anti-infective Drugs for Animals Product Portfolio Table 89. Elanco Recent Development Table 90. Merck Company Information Table 91. Merck Business Overview Table 92. Merck Anti-infective Drugs for Animals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Merck Anti-infective Drugs for Animals Product Portfolio Table 94. Merck Recent Development Table 95. Ceva Santé Animale Company Information Table 96. Ceva Santé Animale Business Overview Table 97. Ceva Santé Animale Anti-infective Drugs for Animals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Ceva Santé Animale Anti-infective Drugs for Animals Product Portfolio Table 99. Ceva Santé Animale Recent Development Table 100. Zoetis Inc. Company Information Table 101. Zoetis Inc. Business Overview Table 102. Zoetis Inc. Anti-infective Drugs for Animals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Zoetis Inc. Anti-infective Drugs for Animals Product Portfolio Table 104. Zoetis Inc. Recent Development Table 105. North America Anti-infective Drugs for Animals Revenue by Type (2021-2026) & (US$ Million) Table 106. North America Anti-infective Drugs for Animals Revenue by Type (2027-2032) & (US$ Million) Table 107. North America Anti-infective Drugs for Animals Sales by Type (2021-2026) & (K Units) Table 108. North America Anti-infective Drugs for Animals Sales by Type (2027-2032) & (K Units) Table 109. North America Anti-infective Drugs for Animals Sales Price by Type (2021-2026) & (US$/Unit) Table 110. North America Anti-infective Drugs for Animals Sales Price by Type (2027-2032) & (US$/Unit) Table 111. North America Anti-infective Drugs for Animals Revenue by Application (2021-2026) & (US$ Million) Table 112. North America Anti-infective Drugs for Animals Revenue by Application (2027-2032) & (US$ Million) Table 113. North America Anti-infective Drugs for Animals Sales by Application (2021-2026) & (K Units) Table 114. North America Anti-infective Drugs for Animals Sales by Application (2027-2032) & (K Units) Table 115. North America Anti-infective Drugs for Animals Sales Price by Application (2021-2026) & (US$/Unit) Table 116. North America Anti-infective Drugs for Animals Sales Price by Application (2027-2032) & (US$/Unit) Table 117. North America Anti-infective Drugs for Animals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. North America Anti-infective Drugs for Animals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 119. North America Anti-infective Drugs for Animals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 120. North America Anti-infective Drugs for Animals Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 121. North America Anti-infective Drugs for Animals Sales by Country (2021-2026) & (K Units) Table 122. North America Anti-infective Drugs for Animals Sales by Country (2027-2032) & (K Units) Table 123. North America Anti-infective Drugs for Animals Sales Price by Country (2021-2026) & (US$/Unit) Table 124. North America Anti-infective Drugs for Animals Sales Price by Country (2027-2032) & (US$/Unit) Table 125. United States Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Table 126. Canada Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Table 127. Europe Anti-infective Drugs for Animals Revenue by Type (2021-2026) & (US$ Million) Table 128. Europe Anti-infective Drugs for Animals Revenue by Type (2027-2032) & (US$ Million) Table 129. Europe Anti-infective Drugs for Animals Sales by Type (2021-2026) & (K Units) Table 130. Europe Anti-infective Drugs for Animals Sales by Type (2027-2032) & (K Units) Table 131. Europe Anti-infective Drugs for Animals Sales Price by Type (2021-2026) & (US$/Unit) Table 132. Europe Anti-infective Drugs for Animals Sales Price by Type (2027-2032) & (US$/Unit) Table 133. Europe Anti-infective Drugs for Animals Revenue by Application (2021-2026) & (US$ Million) Table 134. Europe Anti-infective Drugs for Animals Revenue by Application (2027-2032) & (US$ Million) Table 135. Europe Anti-infective Drugs for Animals Sales by Application (2021-2026) & (K Units) Table 136. Europe Anti-infective Drugs for Animals Sales by Application (2027-2032) & (K Units) Table 137. Europe Anti-infective Drugs for Animals Sales Price by Application (2021-2026) & (US$/Unit) Table 138. Europe Anti-infective Drugs for Animals Sales Price by Application (2027-2032) & (US$/Unit) Table 139. Europe Anti-infective Drugs for Animals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Europe Anti-infective Drugs for Animals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 141. Europe Anti-infective Drugs for Animals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 142. Europe Anti-infective Drugs for Animals Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 143. Europe Anti-infective Drugs for Animals Sales by Country (2021-2026) & (K Units) Table 144. Europe Anti-infective Drugs for Animals Sales by Country (2027-2032) & (K Units) Table 145. Europe Anti-infective Drugs for Animals Sales Price by Country (2021-2026) & (US$/Unit) Table 146. Europe Anti-infective Drugs for Animals Sales Price by Country (2027-2032) & (US$/Unit) Table 147. Germany Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Table 148. France Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Table 149. U.K. Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Table 150. Italy Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Table 151. Netherlands Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Table 152. China Anti-infective Drugs for Animals Revenue by Type (2021-2026) & (US$ Million) Table 153. China Anti-infective Drugs for Animals Revenue by Type (2027-2032) & (US$ Million) Table 154. China Anti-infective Drugs for Animals Sales by Type (2021-2026) & (K Units) Table 155. China Anti-infective Drugs for Animals Sales by Type (2027-2032) & (K Units) Table 156. China Anti-infective Drugs for Animals Sales Price by Type (2021-2026) & (US$/Unit) Table 157. China Anti-infective Drugs for Animals Sales Price by Type (2027-2032) & (US$/Unit) Table 158. China Anti-infective Drugs for Animals Revenue by Application (2021-2026) & (US$ Million) Table 159. China Anti-infective Drugs for Animals Revenue by Application (2027-2032) & (US$ Million) Table 160. China Anti-infective Drugs for Animals Sales by Application (2021-2026) & (K Units) Table 161. China Anti-infective Drugs for Animals Sales by Application (2027-2032) & (K Units) Table 162. China Anti-infective Drugs for Animals Sales Price by Application (2021-2026) & (US$/Unit) Table 163. China Anti-infective Drugs for Animals Sales Price by Application (2027-2032) & (US$/Unit) Table 164. Asia Anti-infective Drugs for Animals Revenue by Type (2021-2026) & (US$ Million) Table 165. Asia Anti-infective Drugs for Animals Revenue by Type (2027-2032) & (US$ Million) Table 166. Asia Anti-infective Drugs for Animals Sales by Type (2021-2026) & (K Units) Table 167. Asia Anti-infective Drugs for Animals Sales by Type (2027-2032) & (K Units) Table 168. Asia Anti-infective Drugs for Animals Sales Price by Type (2021-2026) & (US$/Unit) Table 169. Asia Anti-infective Drugs for Animals Sales Price by Type (2027-2032) & (US$/Unit) Table 170. Asia Anti-infective Drugs for Animals Revenue by Application (2021-2026) & (US$ Million) Table 171. Asia Anti-infective Drugs for Animals Revenue by Application (2027-2032) & (US$ Million) Table 172. Asia Anti-infective Drugs for Animals Sales by Application (2021-2026) & (K Units) Table 173. Asia Anti-infective Drugs for Animals Sales by Application (2027-2032) & (K Units) Table 174. Asia Anti-infective Drugs for Animals Sales Price by Application (2021-2026) & (US$/Unit) Table 175. Asia Anti-infective Drugs for Animals Sales Price by Application (2027-2032) & (US$/Unit) Table 176. Asia Anti-infective Drugs for Animals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. Asia Anti-infective Drugs for Animals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. Asia Anti-infective Drugs for Animals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. Asia Anti-infective Drugs for Animals Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 180. Asia Anti-infective Drugs for Animals Sales by Country (2021-2026) & (K Units) Table 181. Asia Anti-infective Drugs for Animals Sales by Country (2027-2032) & (K Units) Table 182. Asia Anti-infective Drugs for Animals Sales Price by Country (2021-2026) & (US$/Unit) Table 183. Asia Anti-infective Drugs for Animals Sales Price by Country (2027-2032) & (US$/Unit) Table 184. Japan Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Table 185. South Korea Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Table 186. India Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Table 187. Australia Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Table 188. China Taiwan Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Table 189. Southeast Asia Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Table 190. SAMEA Anti-infective Drugs for Animals Revenue by Type (2021-2026) & (US$ Million) Table 191. SAMEA Anti-infective Drugs for Animals Revenue by Type (2027-2032) & (US$ Million) Table 192. SAMEA Anti-infective Drugs for Animals Sales by Type (2021-2026) & (K Units) Table 193. SAMEA Anti-infective Drugs for Animals Sales by Type (2027-2032) & (K Units) Table 194. SAMEA Anti-infective Drugs for Animals Sales Price by Type (2021-2026) & (US$/Unit) Table 195. SAMEA Anti-infective Drugs for Animals Sales Price by Type (2027-2032) & (US$/Unit) Table 196. SAMEA Anti-infective Drugs for Animals Revenue by Application (2021-2026) & (US$ Million) Table 197. SAMEA Anti-infective Drugs for Animals Revenue by Application (2027-2032) & (US$ Million) Table 198. SAMEA Anti-infective Drugs for Animals Sales by Application (2021-2026) & (K Units) Table 199. SAMEA Anti-infective Drugs for Animals Sales by Application (2027-2032) & (K Units) Table 200. SAMEA Anti-infective Drugs for Animals Sales Price by Application (2021-2026) & (US$/Unit) Table 201. SAMEA Anti-infective Drugs for Animals Sales Price by Application (2027-2032) & (US$/Unit) Table 202. SAMEA Anti-infective Drugs for Animals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 203. SAMEA Anti-infective Drugs for Animals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 204. SAMEA Anti-infective Drugs for Animals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 205. SAMEA Anti-infective Drugs for Animals Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 206. SAMEA Anti-infective Drugs for Animals Sales by Country (2021-2026) & (K Units) Table 207. SAMEA Anti-infective Drugs for Animals Sales by Country (2027-2032) & (K Units) Table 208. SAMEA Anti-infective Drugs for Animals Sales Price by Country (2021-2026) & (US$/Unit) Table 209. SAMEA Anti-infective Drugs for Animals Sales Price by Country (2027-2032) & (US$/Unit) Table 210. Brazil Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Table 211. Argentina Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Table 212. Chile Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Table 213. Colombia Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Table 214. Peru Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Table 215. Saudi Arabia Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Table 216. Israel Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Table 217. UAE Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Table 218. Turkey Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Table 219. Iran Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Table 220. Egypt Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Anti-infective Drugs for Animals Distributors List Table 224. Anti-infective Drugs for Animals Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Anti-infective Drugs for Animals Image Figure 2. Global Anti-infective Drugs for Animals Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-infective Drugs for Animals Market Size Share 2021 VS 2025 VS 2032 Figure 4. Antifungals Image Figure 5. Antibacterial Image Figure 6. Antivirals Image Figure 7. Others Image Figure 8. Global Anti-infective Drugs for Animals Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Anti-infective Drugs for Animals Market Size Share 2021 VS 2025 VS 2032 Figure 10. Cattle Image Figure 11. Cats Image Figure 12. Dogs Image Figure 13. Other Animals Image Figure 14. Global Anti-infective Drugs for Animals Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Anti-infective Drugs for Animals Revenue (2021-2032) & (US$ Million) Figure 16. Global Anti-infective Drugs for Animals Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Anti-infective Drugs for Animals Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Anti-infective Drugs for Animals Revenue Market Share by Region (2021-2032) Figure 19. Global Anti-infective Drugs for Animals Sales (2021-2032) & (K Units) Figure 20. Global Anti-infective Drugs for Animals Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Anti-infective Drugs for Animals Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Anti-infective Drugs for Animals Sales YoY (2021-2032) & (K Units) Figure 23. Europe Anti-infective Drugs for Animals Sales YoY (2021-2032) & (K Units) Figure 24. China Anti-infective Drugs for Animals Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Anti-infective Drugs for Animals Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Anti-infective Drugs for Animals Sales YoY (2021-2032) & (K Units) Figure 27. Global Anti-infective Drugs for Animals Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Anti-infective Drugs for Animals Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Anti-infective Drugs for Animals Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Anti-infective Drugs for Animals Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Anti-infective Drugs for Animals Revenue Market Share by Type (2021-2032) Figure 33. Global Anti-infective Drugs for Animals Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Anti-infective Drugs for Animals Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Anti-infective Drugs for Animals Sales Market Share by Type (2021-2032) Figure 36. Global Anti-infective Drugs for Animals Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Anti-infective Drugs for Animals Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Anti-infective Drugs for Animals Revenue Market Share by Application (2021-2032) Figure 39. Global Anti-infective Drugs for Animals Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Anti-infective Drugs for Animals Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Anti-infective Drugs for Animals Sales Market Share by Application (2021-2032) Figure 42. North America Anti-infective Drugs for Animals Revenue Share by Type (2021-2032) Figure 43. North America Anti-infective Drugs for Animals Sales Share by Type (2021-2032) Figure 44. North America Anti-infective Drugs for Animals Revenue Share by Application (2021-2032) Figure 45. North America Anti-infective Drugs for Animals Sales Share by Application (2021-2032) Figure 46. North America Anti-infective Drugs for Animals Revenue Share by Country (2021-2032) Figure 47. North America Anti-infective Drugs for Animals Sales Share by Country (2021-2032) Figure 48. Europe Anti-infective Drugs for Animals Revenue Share by Type (2021-2032) Figure 49. Europe Anti-infective Drugs for Animals Sales Share by Type (2021-2032) Figure 50. Europe Anti-infective Drugs for Animals Revenue Share by Application (2021-2032) Figure 51. Europe Anti-infective Drugs for Animals Sales Share by Application (2021-2032) Figure 52. Europe Anti-infective Drugs for Animals Revenue Share by Country (2021-2032) Figure 53. Europe Anti-infective Drugs for Animals Sales Share by Country (2021-2032) Figure 54. China Anti-infective Drugs for Animals Revenue Share by Type (2021-2032) Figure 55. China Anti-infective Drugs for Animals Sales Share by Type (2021-2032) Figure 56. China Anti-infective Drugs for Animals Revenue Share by Application (2021-2032) Figure 57. China Anti-infective Drugs for Animals Sales Share by Application (2021-2032) Figure 58. Asia Anti-infective Drugs for Animals Revenue Share by Type (2021-2032) Figure 59. Asia Anti-infective Drugs for Animals Sales Share by Type (2021-2032) Figure 60. Asia Anti-infective Drugs for Animals Revenue Share by Application (2021-2032) Figure 61. Asia Anti-infective Drugs for Animals Sales Share by Application (2021-2032) Figure 62. Asia Anti-infective Drugs for Animals Revenue Share by Country (2021-2032) Figure 63. Asia Anti-infective Drugs for Animals Sales Share by Country (2021-2032) Figure 64. SAMEA Anti-infective Drugs for Animals Revenue Share by Type (2021-2032) Figure 65. SAMEA Anti-infective Drugs for Animals Sales Share by Type (2021-2032) Figure 66. SAMEA Anti-infective Drugs for Animals Revenue Share by Application (2021-2032) Figure 67. SAMEA Anti-infective Drugs for Animals Sales Share by Application (2021-2032) Figure 68. SAMEA Anti-infective Drugs for Animals Revenue Share by Country (2021-2032) Figure 69. SAMEA Anti-infective Drugs for Animals Sales Share by Country (2021-2032) Figure 70. Anti-infective Drugs for Animals Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Anti-infective Drugs for Animals Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Antifungals
  • Antibacterial
  • Antivirals
  • Others
Applications
  • Cattle
  • Cats
  • Dogs
  • Other Animals
Companies covered
  • AG Supply
  • Vetoquinol SA
  • Bayer
  • Boehringer Ingelheim
  • Phibro Animal Health Corporation
  • Elanco
  • Merck
  • Ceva Santé Animale
  • Zoetis Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Anti-infective Drugs for Animals Market by Type
  3. 1.2.1 Global Anti-infective Drugs for Animals Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Antifungals
  5. 1.2.3 Antibacterial
  6. 1.2.4 Antivirals
  7. 1.2.5 Others
  8. 1.3 Anti-infective Drugs for Animals Market by Application
  9. 1.3.1 Global Anti-infective Drugs for Animals Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Cattle
  11. 1.3.3 Cats
  12. 1.3.4 Dogs
  13. 1.3.5 Other Animals
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Anti-infective Drugs for Animals Market Dynamics
  1. 2.1 Anti-infective Drugs for Animals Industry Trends
  2. 2.2 Anti-infective Drugs for Animals Industry Drivers
  3. 2.3 Anti-infective Drugs for Animals Industry Opportunities and Challenges
  4. 2.4 Anti-infective Drugs for Animals Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Anti-infective Drugs for Animals Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Anti-infective Drugs for Animals Revenue by Region
  3. 3.2.1 Global Anti-infective Drugs for Animals Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Anti-infective Drugs for Animals Revenue by Region (2021-2026)
  5. 3.2.3 Global Anti-infective Drugs for Animals Revenue by Region (2027-2032)
  6. 3.2.4 Global Anti-infective Drugs for Animals Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Anti-infective Drugs for Animals Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Anti-infective Drugs for Animals Sales by Region
  9. 3.4.1 Global Anti-infective Drugs for Animals Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Anti-infective Drugs for Animals Sales by Region (2021-2026)
  11. 3.4.3 Global Anti-infective Drugs for Animals Sales by Region (2027-2032)
  12. 3.4.4 Global Anti-infective Drugs for Animals Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Anti-infective Drugs for Animals Revenue by Manufacturers
  2. 4.1.1 Global Anti-infective Drugs for Animals Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Anti-infective Drugs for Animals Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Anti-infective Drugs for Animals Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Anti-infective Drugs for Animals Sales by Manufacturers
  6. 4.2.1 Global Anti-infective Drugs for Animals Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Anti-infective Drugs for Animals Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Anti-infective Drugs for Animals Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Anti-infective Drugs for Animals Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Anti-infective Drugs for Animals Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Anti-infective Drugs for Animals Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Anti-infective Drugs for Animals Manufacturers, Product Type & Application
  13. 4.7 Global Anti-infective Drugs for Animals Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Anti-infective Drugs for Animals Market CR5 and HHI
  16. 4.8.2 2025 Anti-infective Drugs for Animals Tier 1, Tier 2, and Tier 3
5 Anti-infective Drugs for Animals Market by Type
  1. 5.1 Global Anti-infective Drugs for Animals Revenue by Type
  2. 5.1.1 Global Anti-infective Drugs for Animals Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Anti-infective Drugs for Animals Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Anti-infective Drugs for Animals Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Anti-infective Drugs for Animals Sales by Type
  6. 5.2.1 Global Anti-infective Drugs for Animals Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Anti-infective Drugs for Animals Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Anti-infective Drugs for Animals Sales Market Share by Type (2021-2032)
  9. 5.3 Global Anti-infective Drugs for Animals Price by Type
6 Anti-infective Drugs for Animals Market by Application
  1. 6.1 Global Anti-infective Drugs for Animals Revenue by Application
  2. 6.1.1 Global Anti-infective Drugs for Animals Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Anti-infective Drugs for Animals Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Anti-infective Drugs for Animals Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Anti-infective Drugs for Animals Sales by Application
  6. 6.2.1 Global Anti-infective Drugs for Animals Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Anti-infective Drugs for Animals Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Anti-infective Drugs for Animals Sales Market Share by Application (2021-2032)
  9. 6.3 Global Anti-infective Drugs for Animals Price by Application
7 Company Profiles
  1. 7.1 AG Supply
  2. 7.1.1 AG Supply Company Information
  3. 7.1.2 AG Supply Business Overview
  4. 7.1.3 AG Supply Anti-infective Drugs for Animals Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 AG Supply Anti-infective Drugs for Animals Product Portfolio
  6. 7.1.5 AG Supply Recent Developments
  7. 7.2 Vetoquinol SA
  8. 7.2.1 Vetoquinol SA Company Information
  9. 7.2.2 Vetoquinol SA Business Overview
  10. 7.2.3 Vetoquinol SA Anti-infective Drugs for Animals Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Vetoquinol SA Anti-infective Drugs for Animals Product Portfolio
  12. 7.2.5 Vetoquinol SA Recent Developments
  13. 7.3 Bayer
  14. 7.3.1 Bayer Company Information
  15. 7.3.2 Bayer Business Overview
  16. 7.3.3 Bayer Anti-infective Drugs for Animals Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bayer Anti-infective Drugs for Animals Product Portfolio
  18. 7.3.5 Bayer Recent Developments
  19. 7.4 Boehringer Ingelheim
  20. 7.4.1 Boehringer Ingelheim Company Information
  21. 7.4.2 Boehringer Ingelheim Business Overview
  22. 7.4.3 Boehringer Ingelheim Anti-infective Drugs for Animals Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Boehringer Ingelheim Anti-infective Drugs for Animals Product Portfolio
  24. 7.4.5 Boehringer Ingelheim Recent Developments
  25. 7.5 Phibro Animal Health Corporation
  26. 7.5.1 Phibro Animal Health Corporation Company Information
  27. 7.5.2 Phibro Animal Health Corporation Business Overview
  28. 7.5.3 Phibro Animal Health Corporation Anti-infective Drugs for Animals Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Phibro Animal Health Corporation Anti-infective Drugs for Animals Product Portfolio
  30. 7.5.5 Phibro Animal Health Corporation Recent Developments
  31. 7.6 Elanco
  32. 7.6.1 Elanco Company Information
  33. 7.6.2 Elanco Business Overview
  34. 7.6.3 Elanco Anti-infective Drugs for Animals Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Elanco Anti-infective Drugs for Animals Product Portfolio
  36. 7.6.5 Elanco Recent Developments
  37. 7.7 Merck
  38. 7.7.1 Merck Company Information
  39. 7.7.2 Merck Business Overview
  40. 7.7.3 Merck Anti-infective Drugs for Animals Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Merck Anti-infective Drugs for Animals Product Portfolio
  42. 7.7.5 Merck Recent Developments
  43. 7.8 Ceva Santé Animale
  44. 7.8.1 Ceva Santé Animale Company Information
  45. 7.8.2 Ceva Santé Animale Business Overview
  46. 7.8.3 Ceva Santé Animale Anti-infective Drugs for Animals Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Ceva Santé Animale Anti-infective Drugs for Animals Product Portfolio
  48. 7.8.5 Ceva Santé Animale Recent Developments
  49. 7.9 Zoetis Inc.
  50. 7.9.1 Zoetis Inc. Company Information
  51. 7.9.2 Zoetis Inc. Business Overview
  52. 7.9.3 Zoetis Inc. Anti-infective Drugs for Animals Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Zoetis Inc. Anti-infective Drugs for Animals Product Portfolio
  54. 7.9.5 Zoetis Inc. Recent Developments
8 North America
  1. 8.1 North America Anti-infective Drugs for Animals Market Size by Type
  2. 8.1.1 North America Anti-infective Drugs for Animals Revenue by Type (2021-2032)
  3. 8.1.2 North America Anti-infective Drugs for Animals Sales by Type (2021-2032)
  4. 8.1.3 North America Anti-infective Drugs for Animals Price by Type (2021-2032)
  5. 8.2 North America Anti-infective Drugs for Animals Market Size by Application
  6. 8.2.1 North America Anti-infective Drugs for Animals Revenue by Application (2021-2032)
  7. 8.2.2 North America Anti-infective Drugs for Animals Sales by Application (2021-2032)
  8. 8.2.3 North America Anti-infective Drugs for Animals Price by Application (2021-2032)
  9. 8.3 North America Anti-infective Drugs for Animals Market Size by Country
  10. 8.3.1 North America Anti-infective Drugs for Animals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Anti-infective Drugs for Animals Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Anti-infective Drugs for Animals Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Anti-infective Drugs for Animals Market Size by Type
  2. 9.1.1 Europe Anti-infective Drugs for Animals Revenue by Type (2021-2032)
  3. 9.1.2 Europe Anti-infective Drugs for Animals Sales by Type (2021-2032)
  4. 9.1.3 Europe Anti-infective Drugs for Animals Price by Type (2021-2032)
  5. 9.2 Europe Anti-infective Drugs for Animals Market Size by Application
  6. 9.2.1 Europe Anti-infective Drugs for Animals Revenue by Application (2021-2032)
  7. 9.2.2 Europe Anti-infective Drugs for Animals Sales by Application (2021-2032)
  8. 9.2.3 Europe Anti-infective Drugs for Animals Price by Application (2021-2032)
  9. 9.3 Europe Anti-infective Drugs for Animals Market Size by Country
  10. 9.3.1 Europe Anti-infective Drugs for Animals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Anti-infective Drugs for Animals Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Anti-infective Drugs for Animals Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Anti-infective Drugs for Animals Market Size by Type
  2. 10.1.1 China Anti-infective Drugs for Animals Revenue by Type (2021-2032)
  3. 10.1.2 China Anti-infective Drugs for Animals Sales by Type (2021-2032)
  4. 10.1.3 China Anti-infective Drugs for Animals Price by Type (2021-2032)
  5. 10.2 China Anti-infective Drugs for Animals Market Size by Application
  6. 10.2.1 China Anti-infective Drugs for Animals Revenue by Application (2021-2032)
  7. 10.2.2 China Anti-infective Drugs for Animals Sales by Application (2021-2032)
  8. 10.2.3 China Anti-infective Drugs for Animals Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Anti-infective Drugs for Animals Market Size by Type
  2. 11.1.1 Asia Anti-infective Drugs for Animals Revenue by Type (2021-2032)
  3. 11.1.2 Asia Anti-infective Drugs for Animals Sales by Type (2021-2032)
  4. 11.1.3 Asia Anti-infective Drugs for Animals Price by Type (2021-2032)
  5. 11.2 Asia Anti-infective Drugs for Animals Market Size by Application
  6. 11.2.1 Asia Anti-infective Drugs for Animals Revenue by Application (2021-2032)
  7. 11.2.2 Asia Anti-infective Drugs for Animals Sales by Application (2021-2032)
  8. 11.2.3 Asia Anti-infective Drugs for Animals Price by Application (2021-2032)
  9. 11.3 Asia Anti-infective Drugs for Animals Market Size by Country
  10. 11.3.1 Asia Anti-infective Drugs for Animals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Anti-infective Drugs for Animals Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Anti-infective Drugs for Animals Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Anti-infective Drugs for Animals Market Size by Type
  2. 12.1.1 SAMEA Anti-infective Drugs for Animals Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Anti-infective Drugs for Animals Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Anti-infective Drugs for Animals Price by Type (2021-2032)
  5. 12.2 SAMEA Anti-infective Drugs for Animals Market Size by Application
  6. 12.2.1 SAMEA Anti-infective Drugs for Animals Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Anti-infective Drugs for Animals Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Anti-infective Drugs for Animals Price by Application (2021-2032)
  9. 12.3 SAMEA Anti-infective Drugs for Animals Market Size by Country
  10. 12.3.1 SAMEA Anti-infective Drugs for Animals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Anti-infective Drugs for Animals Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Anti-infective Drugs for Animals Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Anti-infective Drugs for Animals Value Chain Analysis
  2. 13.1.1 Anti-infective Drugs for Animals Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Anti-infective Drugs for Animals Production Mode & Process
  6. 13.2 Anti-infective Drugs for Animals Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Anti-infective Drugs for Animals Distributors
  9. 13.2.3 Anti-infective Drugs for Animals Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research